Medlab Clinical Overview

  • Founded
  • 2012

Founded
  • Status
  • Public

  • Employees
  • 48

Employees
  • Stock Symbol
  • MDC

Stock Symbol
  • Share Price
  • $7.09

  • (As of Wednesday Closing)

Medlab Clinical General Information

Description

Medlab Clinical Ltd is a medical research and development company. It is engaged in researching and formulating novel biotherapeutics to improve health outcomes in early to moderate stage chronic diseases such as chronic kidney disease, pre-diabetes, and obesity. Some of the company's nutraceutical products are Multibiotic, Mg Optima Relax, NRGBiotic, NanoCelle D3, SB 5B and others. The principal segments of the group are Nutraceutical which includes the sale of nutraceutical products; and Pharmaceutical research. It generates the majority of the revenue from the sale of nutraceutical products. The business operations of the firm are carried out from Australia.

Contact Information

Website
www.medlab.co
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
ASX
Primary Office
  • 11-13 Lord Strret Botany
  • Building A, Unit A5 A6, Botany Quarter
  • Sydney, New South Wales 2019
  • Australia
+61 (02) 0000 0000

Medlab Clinical Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Medlab Clinical Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$7.09 $7.38 $4.48 - $22.22 $16.2M 2.28M 1.47K

Medlab Clinical Financials Summary

In Thousands,
USD
TTM 30-Jun-2022 FY 2022 30-Jun-2022 FY 2021 30-Jun-2021 FY 2020 30-Jun-2020
EV 8,272 8,272 28,278 23,025
Revenue 3,280 1,908
EBITDA (8,511) (8,310)
Net Income (9,188) (8,975)
Total Assets 15,512 12,223
Total Debt 1,274 1,604
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Medlab Clinical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Medlab Clinical‘s full profile, request access.

Request a free trial

Medlab Clinical Patents

Medlab Clinical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021903495-A0 Fabric products Pending 02-Nov-2021
AU-2021902932-A0 Probiotic compositions and uses thereof Pending 10-Sep-2021
AU-2021901053-A0 Compositions Pending 12-Apr-2021
AU-2021900459-A0 Combination therapy Pending 22-Feb-2021
AU-2020903959-A0 Fabric products Pending 30-Oct-2020
To view Medlab Clinical’s complete patent history, request access »

Medlab Clinical Executive Team (4)

Name Title Board Seat Contact Info
Sean Hall Chief Executive Officer & Managing Director
Kerem Kaya Chief Financial Officer & Company Secretary
Ian Curtinsmith Chief Information Officer
You’re viewing 3 of 4 executive team members. Get the full list »

Medlab Clinical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial